GlassScriptPhysician profile
Nure B Khoury
NPI 1295267037
$31,493.89
in general payments reported to CMS, 2019-2025
11 companies · $5,458 in 2025
The $5,458 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $80.73 · 2022: $24.76 · 2023: $36.70 · 2024: $26K · 2025: $5,458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $25K · Travel and Lodging: $4,601 · Food and Beverage: $1,787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $25,000.00 |
| Travel and Lodging | $4,601.01 |
| Food and Beverage | $1,787.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $26,069.63 | 2024-2025 | Trufill, Cerenovus Enterprise, Emboguard |
| Penumbra, INC. | $2,698.94 | 2024-2025 | Penumbra System, Red 72 |
| Medtronic, INC. | $1,583.86 | 2024-2025 | Pipeline, Axium Primetm |
| Microvention, INC. | $667.36 | 2025 | Stent, Web Aneurysm Embolization System, Eric Retrieval Device |
| Depuy Synthes Sales INC. | $331.91 | 2024-2025 | Embotrap, Cerepak Uniform, Emboguard |
| Ns Pharma, INC. | $53.00 | 2021 | |
| Emd Serono, INC. | $24.76 | 2022 | |
| Abbvie INC. | $18.57 | 2023 | |
| Argenx US, INC. | $18.13 | 2023 | Vyvgart Hytrulo |
| Ibsa Pharma INC. | $15.82 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nure Khoury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.